|
Natto-K
contains a
synergistic blend of Nattokinase NSK-SD (800 FU per capsule),
Protease, Lipase, and Amylase, which has been shown to have a high
fibrinolytic activity (breaks down fibrin). Excess fibrin has been
shown to contribute to cardiovascular issues, high blood pressure,
poor circulation and slow tissue repair.
Product No. EN22030 - $24.95
(30 Capsules per bottle)
Product No. EN22090 - $69.95
(90 Capsules per bottle)
|
 |
|
Each capsule of
Natto-K provides:
Nattokinase NSK-SD* .. . . . . . . . . . . . .800FU
Amylase Thera-blend™
. . . . . . . . . ..3,600
DU
ProteaseThera-blend™
. . . . . . . . .16,000
HUT
LipaseThera-blend™
. . . . . . . . . ..600
FCCFIP
Cellulase Thera-blend™
. . .
. . . . . . .1,000 CU
Bromelain . . . . . . . . . . . . . . . .1,800,000 PU**
Mineral Blend . . . . . . . . . . . . . . . . . . . .40 mg
GlucoAmylase . . . . . . . . . . . . . . . . . .40 AGU
30 & 90 capsules per bottle. No fillers.
*Nattokinase NSK-SD
is the only Nattokinase that has been studied for its effectiveness
and efficacy in this regard.
**
1,800,000 PU=96
GDU
Enzymedica uses an exclusive Thera-blend process for its protease,
lipase, amylase and cellulase. Each of these enzymes actually
represents multiple strains which are blended for their ability to
break down numerous bonds in varying pH’s.
* These
statements have not been evaluated by the Food and Drug
Administration. |
|
Recommended
Usage:
One capsule
right before bed. For a therapeutic effect, one capsule three times
a day More may be taken as needed (two capsules three times a day
for chronic issues is sometimes recommended).
References:
1.
Natto-Traditional Japanese Fermented Soy Beans with Recently
Discovered Health Benefits and Novel Industrial Applications, Enzyme
Wave, Volume 3, June 2002, Amano Enzyme, Inc., page 2-4.
2.
Maruyama
M, Sumi H. Effect of Natto Diet on Blood Pressure. JTTAS,1995.
3.
Sumi H,
Hamada H, Tsushima H, Mihara H, Muraki H. A novel fibrinolytic
enzyme (nattokinase) in the vegetable cheese Natto; a typical and
popular soybean food in the Japanese diet. Experientia 1987, Oct
15;43(10):1110-1.
4.
Sumi H. Healthy
Microbe “Bacillus natto”. Japan Bio Science Laboratory Co. Ltd. |
Fibrin
Fibrin is a
protein that forms in the blood after trauma or injury. This is
essential to stop excess blood loss. There are more than twenty
enzymes in the body that assist in clotting the blood, while only
one that can break the clot down (plasmin). Bacteria, viruses, fungi
and toxins present in the blood also trigger an inflammatory
condition resulting in excess cross-linked fibrin. Since there is no
danger of blood loss and trauma has not occurred, this cross-linked
fibrin will circulate through the blood and will stick to the walls
of blood vessels. This contributes to the formation of blood clots,
slows blood flow and increases blood viscosity contributing to the
elevation of blood pressure.
Discovery
Dr. Hiroyuki
Sumi, M.D. (a.k.a, Dr. Natto) a researcher of the Japan Ministry of
Education and majoring in the physiological chemistry at the blood
laboratory of the University of Chicago, had long researched
thrombolytic enzymes. He was searching for a natural agent that
could successfully dissolve thrombus associated with cardiac and
cerebral infarction (blood clots associated with heart attacks and
stroke). Dr. Sumi found that the sticky part of natto, commonly
called “threads”, exhibited a strong fibrinolytic (“blood clot
busting”) activity. He named the corresponding fibrinolytic enzyme “nattokinase”.
Dr. Sumi commented that Nattokinase showed “a potency matched by no
other enzyme.” 1,4
Proof
Nattokinase has
been the subject of 17 studies, including two small human trials.
Researchers from JCR Pharmaceuticals, Oklahoma State University, and
Miyazaki Medical College tested nattokinase on 12 healthy Japanese
volunteers (6 men and 6 women, between the ages of 21 and 55). They
gave the volunteers 200 grams of natto (the food) before breakfast,
then tracked fibrinolytic activity through a series of blood plasma
tests. The tests indicated that the natto generated a heightened
ability to dissolve blood clots. On average, the volunteers’ ELT (a
measure of how long it takes to dissolve a blood clot) dropped by 48
percent within two hours of treatment, and volunteers retained an
enhanced ability to dissolve blood clots for 2 to 8 hours. An
additional study showed an 11% decrease in blood pressure after just
two weeks.1,2,3. |
